Chronic obstructive pulmonary disease
Conditions
Interventions
Control group:Received intervention based on the traditional chronic obstructive pulmonary disease rehabilitation treatment model for 10 weeks
Experimental group:Received the intervention of the digital lung rehabilitation program for chronic obstructive pulmonary disease based on PDCA for 10 weeks
Sponsors
Beijing Chao-Yang Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Diagnosed with chronic obstructive pulmonary disease, with pulmonary function at GOLD 1-3 level; 2.Age ranging from 40 to 80 years old; 3.Possessing a smart phone and proficient in using apps; 4.Willing to undergo follow-up and having signed the informed consent form;
Exclusion criteria
Exclusion criteria: 1.Suffering from diseases such as tuberculosis-induced lung damage, thoracic deformity, extreme weakness, impaired vision or balance ability; 2.Suffering from malignant tumors, liver and kidney failure, bone and joint diseases, and other diseases causing limb movement disorders; 3.Having experienced unstable angina pectoris within the last month, acute myocardial infarction within half a year, severe arrhythmia, heart failure, and patients with hypertension whose blood pressure is not well controlled (systolic pressure > 140 mmHg and/or diastolic pressure > 90 mmHg); 4.Cognition impairment; 5.Combined respiratory failure; 6.Having participated in a pulmonary rehabilitation clinical trial within 6 months prior to enrollment; 7.Expected survival time of less than 1 year;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in CAT score before and after intervention; | — |
Secondary
| Measure | Time frame |
|---|---|
| The change of 6MWD, the improvement of lung function related indicators (FEV1, FEV1/FVC), and the improvement of average daily steps before and after intervention;Changes in mMRC grade, quality of life, anxiety and depression scale scores, and sleep quality (PSQI) before and after the intervention.;Adherence to pulmonary rehabilitation exercise, adherence to oral and/or inhaled medication, etc.;Types and proportions of adverse events;Incidence of acute exacerbations; | — |
Countries
China
Contacts
Public ContactLiang Lirong
Beijing Chao-Yang Hospital, Capital Medical University
Outcome results
None listed